Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News

Pharma News

Viriom China Wins Award at 2018 Zhongguancun International Frontier Science and Technology Innovation Competition

Viriom China Wins Award at 2018 Zhongguancun International Frontier Science and Technology Innovation Competition

SAN DIEGO, Jan.

First generic version of epilepsy drug sabril approved

First generic version of epilepsy drug sabril approved

The first generic version of Sabril (vigabatrin) has been approved by the U.

Ertugliflozin seems safe, effective for type 2 diabetes treatment

Ertugliflozin seems safe, effective for type 2 diabetes treatment

Ertugliflozin appears safe and effective at improving long-term glycemic control among adults with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin, according to a study pu...

FDA panel has tie vote on new type 1 diabetes drug

FDA panel has tie vote on new type 1 diabetes drug

(HealthDay)—A U.

Lilly cancer drug fails key trial, will no longer be prescribed

Lilly cancer drug fails key trial, will no longer be prescribed

(Reuters) - Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and wil...

FDA recalls inspectors as shutdown drags on; Gottlieb calls PDUFA most 'vulnerable'

FDA recalls inspectors as shutdown drags on; Gottlieb calls PDUFA most 'vulnerable'

With the government shutdown now in its fourth week—the longest ever—FDA Commissioner Scott Gottlieb, M.

Pfizer partners with Medochemie to make drugs in Vietnam

Pfizer partners with Medochemie to make drugs in Vietnam

Vietnam has transformed its economy from one of the world’s poorest to one that is comfortably middle income.

Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases

Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases

HANGZHOU, China and SHAOXING, China and SUZHOU, China, Jan.

Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients

Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients

HENDERSON, Nev.

BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma

BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma

CAMBRIDGE, Mass.

Researchers Successfully Turn Breast Cancer Cells Into Fat to Stop Them From Spreading

Researchers Successfully Turn Breast Cancer Cells Into Fat to Stop Them From Spreading

Researchers have been able to coax human breast cancer cells to turn into fat cells in a new proof-of-concept study in mice.

Amgen's postmenopausal osteoporosis drug wins FDA panel backing

Amgen's postmenopausal osteoporosis drug wins FDA panel backing

(Reuters) - An advisory panel to the U.

417 418 419 420421422 423 424 425